Michelle T. Dow
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, Genomics and Rare Diseases, Genomics and Phylogenetic Studies, Gene expression and cancer classification
Most-Cited Works
- → An evaluation of copy number variation detection tools for cancer using whole exome sequencing data(2017)156 cited
- → Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation(2021)97 cited
- → The Emerging Potential for Network Analysis to Inform Precision Cancer Medicine(2018)92 cited
- → Integrative genomic analysis of mouse and human hepatocellular carcinoma(2018)88 cited
- → Genome privacy: challenges, technical approaches to mitigate risk, and ethical considerations in the United States(2016)77 cited
- → Learning together: new partnerships for new times(2006)42 cited
- → Immune DNA signature of T-cell infiltration in breast tumor exomes(2016)33 cited
- → Large-Scale Uniform Analysis of Cancer Whole Genomes in Multiple Computing Environments(2017)29 cited
- PREMIX: PRivacy-preserving EstiMation of Individual admiXture.(2016)
- → Increasing metadata coverage of SRA BioSample entries using deep learning–based named entity recognition(2021)20 cited